不妊治療の世界市場予測(~2023年)

MarketsandMarketsが発行した調査報告書(MD-3765)
◆英語タイトル:Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure [ART (IVF, ICSI, Surrogate), Insemination, Laparoscopy, Tubal Ligation], Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Forecasts to 2023
◆商品コード:MD-3765
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2018年11月6日◆ページ数:177
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥836,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

不妊治療の世界市場は、2018年の15億米ドルから2023年には22億米ドルに達し、8.0%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、出生率の低下、不妊治療の選択肢に関する一般の認識の高まりなどが考えれられます。一方で、治療費が高いことと、支援に消極的な政府の規制により、市場の成長は抑制される可能性があります。当調査レポートでは、不妊治療の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品(機器、メディア、関連機器)分析、処置(ART、受精、腹腔鏡検査、卵管結紮)分析、患者のタイプ(女性、男性)分析、エンドユーザー(不妊治療クリニック、病院、精子バンク)分析、不妊治療の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・不妊治療の世界市場:市場インサイト
・不妊治療の世界市場:市場概観/市場動向
・不妊治療の世界市場:市場シェア分析
・不妊治療の世界市場:製品(機器、メディア、関連機器)分析/市場規模
・不妊治療の世界市場:処置(ART、受精、腹腔鏡検査、卵管結紮)分析/市場規模
・不妊治療の世界市場:患者のタイプ(女性、男性)分析/市場規模
・不妊治療の世界市場:エンドユーザー(不妊治療クリニック、病院、精子バンク)分析/市場規模
・不妊治療のアジア市場規模予測
・不妊治療のヨーロッパ市場規模予測
・不妊治療のアメリカ市場規模予測
・不妊治療の世界市場動向
・不妊治療の世界市場:競争状況
・不妊治療の世界市場:関連企業分析
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

“The infertility treatment market is projected to grow at a CAGR of 8.0% during the forecast period.”The global infertility treatment market is projected to reach 2.2 billion by 2023 from USD 1.5 billion in 2018 at a CAGR of 8.0%. Growth in the infertility treatment market can be attributed to factors such as the declining fertility rate and rising public awareness about various infertility treatment options. However, high procedural costs and unsupportive government regulations are the major factors restricting market growth.

“The female infertility treatment segment is expected to hold the largest market share during the forecast period.”
On the basis of patient type, the global infertility treatment market has been segmented into patient infertility treatment and male infertility treatment. The female infertility treatment segment is expected to hold the largest market share during the forecast period. Factors such as decreased rate of fertility in female population and increased range of available treatment options to overcome infertility issues are driving growth in this market segment.

“The fertility centers segment is expected to grow at the highest rate during the forecast period.”
On the basis of end user, the infertility treatment market is segmented into fertility centers, hospitals & surgical clinics, cryobanks, and research institutes. The fertility centers segment is expected to grow at the highest rate during the forecast period. This is mainly due to factors such as the increasing number of fertility centers across the globe and increasing medical tourism in emerging countries.

“The European infertility treatment market is expected to hold the second-largest share during the forecast period.”
Geographically, the infertility treatment market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The Europe market is expected to hold the second-largest share during the forecast period. Growth in this segment is mainly due to the declining fertility rate, growing number of fertility clinics, and increasing number of public-private investments. Moreover, increasing medical tourism in various European countries such as Spain and Italy are also shifting the focus towards the European market, thereby driving the growth of this market during the forecast period.
Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 – 25%, Tier 2 – 30%, and Tier 3 – 45%
• By Designation: C-level – 26%, Director-level – 30%, and Others – 44%
• By Region: North America – 35%, Europe – 26%, APAC – 23%, and RoW – 16%

The major players in the market include The Cooper Companies Inc. (US), Cook Group Incorporated (US), and Vitrolife AB (Sweden), Thermo Fisher Scientific, Inc. (US) Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato (Japan), Rocket Medical Plc (UK), IHMedical A/S (Denmark), Hamilton Throne Ltd. (US), MedGyn Products, Inc. (US), ZEISS Group (Germany), and SOMATEX Medical Technologies GmbH (Germany).

Research Coverage
This report studies the infertility treatment market based on product, procedure, patient type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the infertility treatment market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 GEOGRAPHIC SCOPE 20
1.3.3 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 21
1.5 STAKEHOLDERS 21
2 RESEARCH METHODOLOGY 22
2.1 RESEARCH DATA 22
2.1.1 SECONDARY DATA 24
2.1.1.1 Key data from secondary sources 24
2.1.2 PRIMARY DATA 26
2.1.2.1 Key data from primary sources 26
2.1.2.2 Breakdown of primaries 27
2.1.3 MARKET SIZE ESTIMATION 27
2.1.3.1 Product-based Market Estimation 27
2.1.4 PRIMARY RESEARCH VALIDATION 29
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 30
2.2.1 LIMITATIONS 31
2.2.2 ASSUMPTIONS FOR THE STUDY 31
3 EXECUTIVE SUMMARY 32
4 PREMIUM INSIGHTS 36
4.1 INFERTILITY TREATMENT: MARKET OVERVIEW 36
4.2 GEOGRAPHIC ANALYSIS: INFERTILITY TREATMENT MARKET, BY PRODUCT 36
4.3 ASIA PACIFIC: INFERTILITY TREATMENT MARKET SHARE, BY PROCEDURE (2018) 37
4.4 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2018 VS. 2023 (USD MILLION) 38
4.5 INFERTILITY TREATMENT MARKET, BY END USER, 2018 VS. 2023 (USD MILLION) 39
4.6 GEOGRAPHICAL SNAPSHOT OF THE INFERTILITY TREATMENT MARKET 40

5 MARKET OVERVIEW 41
5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
5.2.1 DRIVERS 42
5.2.1.1 Declining fertility rate 42
5.2.1.2 Rising number of fertility clinics worldwide 43
5.2.1.3 Technological advancements 43
5.2.1.3.1 Advancements in infertility treatment devices 43
5.2.1.3.1 Increase in the use of time-lapse technology 44
5.2.1.4 Increasing public-private investments, funds, and grants 45
5.2.2 RESTRAINTS 45
5.2.2.1 High procedural cost of assisted reproductive techniques in developed markets 45
5.2.2.2 Unsupportive government regulations 46
5.2.3 OPPORTUNITIES 47
5.2.3.1 Growth opportunities in emerging markets 47
5.2.3.1.1 Improving healthcare infrastructure 47
5.2.3.1.2 Increasing medical tourism due to low treatment costs 47
5.2.3.2 Use of fertility treatment options by single parents and same-sex couples 48
5.2.4 CHALLENGES 49
5.2.4.1 Concerns related to ART procedures 49
5.2.4.2 Reduced efficacy among older women 50
6 INFERTILITY TREATMENT MARKET, BY PRODUCT 51
6.1 INTRODUCTION 52
6.2 EQUIPMENT 53
6.2.1 MICROSCOPES 54
6.2.1.1 Growing technological advancements in the field of microscopy resulting in the growing adoption of microscopes 54
6.2.2 IMAGING SYSTEMS 55
6.2.2.1 Emergence of time-lapse imaging systems driving the growth of the infertility treatment imaging systems market 55
6.2.3 SPERM ANALYZER SYSTEMS 56
6.2.3.1 Automated sperm analyzer systems permitting internal and external quality control and better reproducibility 56
6.2.4 OVUM ASPIRATION PUMPS 57
6.2.4.1 Ovum aspiration pumps enable smooth collection of oocytes during infertility treatment procedures 57
6.2.5 MICROMANIPULATOR SYSTEMS 57
6.2.5.1 Micromanipulators are commonly used for the treatment of male infertility, particularly cases pertaining to poor sperm quantity/mobility 57

6.2.6 INCUBATORS 59
6.2.6.1 Incubators play a vital role in embryo development and improved clinical outcomes 59
6.2.7 GAS ANALYZERS 60
6.2.7.1 Gas analyzers contain multiple ports enabling analysis of sequential gas samples 60
6.2.8 LASER SYSTEMS 61
6.2.8.1 The common applications of laser systems include treament of stress urinary incontinence and vaginal tightening 61
6.2.9 CRYOSYSTEMS 62
6.2.9.1 Demand for cryosystems is on the rise as women are seeking to extend their childbearing years 62
6.3 MEDIA & CONSUMABLES 63
6.3.1 EASY AVAILABILITY OF CULTURE MEDIA COUPLED WITH THE GROWING AWARENESS AMONG INDIVIDUALS DRIVING THE GROWTH OF THE MEDIA & CONSUMABLES SEGMENT 63
6.4 ACCESSORIES 64
6.4.1 ANTI-VIBRATION TABLES ARE COMMONLY USED FOR IVF TREATMENTS TO PROVIDE A SMOOTH WORKSPACE DURING PROCEDURES 64
7 INFERTILITY TREATMENT MARKET, BY PROCEDURE 65
7.1 INTRODUCTION 66
7.2 ASSISTED REPRODUCTIVE TECHNOLOGY 67
7.2.1 IN VITRO FERTILIZATION 68
7.2.1.1 Intracytoplasmic morphologically selected sperm injection 69
7.2.1.1.1 IMSI is highly recommended in patients with a low sperm count and recurrent implantation failure 69
7.2.1.2 Gamete donation 69
7.2.1.2.1 Increase in the number of women registering as egg donors is a key factor aiding market growth 69
7.2.2 INTRACYTOPLASMIC SPERM INJECTION 70
7.2.2.1 ICSI is a specialized form of IVF involving fertilization used commonly in male infertility treatment procedures 70
7.2.3 SURROGACY 71
7.2.3.1 High success rates guaranteed and achieved with the help of surrogacy are driving market growth 71
7.3 ARTIFICIAL INSEMINATION 72
7.3.1 INTRAUTERINE INSEMINATION 73
7.3.1.1 Limited risk of complications during pregnancy and high success rates driving market demand for IUI procedures 73
7.3.2 INTRACERVICAL INSEMINATION 74
7.3.2.1 Low cost of procedure as compared to other AI procedures leading to increased adoption 74
7.3.3 INTRATUBAL INSEMINATION 74
7.3.3.1 Better chances of successful pregnancies using ITI to drive the demand for this procedure 74
7.4 FERTILITY SURGERY 74
7.4.1 LAPAROSCOPY 76
7.4.1.1 Laparoscopy allows for the biopsy of suspect growths and cysts that hamper fertility 76
7.4.2 HYSTEROSCOPY 76
7.4.2.1 Growing demand for minimally invasive procedures driving the adoption of hysteroscopy infertility treatment surgeries globally 76
7.4.3 MYOMECTOMY 77
7.4.3.1 Advantages of myomectomy in alleviating problems caused due to fibroids while preserving future fertility to drive the demand for this surgery 77
7.4.4 LAPAROTOMY 77
7.4.4.1 Laparotomy is used in common infertility surgeries that require large exposure to the reproductive system 77
7.4.5 TUBAL LIGATION REVERSAL 77
7.4.5.1 Tubal ligation reversal is performed only in women who still have a large portion of healthy fallopian tube remaining 77
7.4.6 VARICOCELECTOMY 78
7.4.6.1 Adoption of varicocelectomy is high among patients and results in a high chance of improved fertility with reduced complications 78
7.4.7 MICROSURGICAL RECONSTRUCTION 78
7.4.7.1 Vasovasostomy 78
7.4.7.1.1 Vasovasostomy is a reversal surgery commonly used in the treatment of infertility in men 78
7.4.7.2 Vasoepididymostomy 79
7.4.7.2.1 Vasoepididymostomy provides a higher pregnancy rate than IVF with ICSI 79
7.5 OTHER INFERTILITY TREATMENT PROCEDURES 79
8 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE 80
8.1 INTRODUCTION 81
8.2 FEMALE INFERTILITY TREATMENT 82
8.2.1 INCREASING FEMALE INFERTILITY RATES TO DRIVE THE GROWTH OF THE FEMALE INFERTILITY TREATMENT MARKET 82
8.3 MALE INFERTILITY TREATMENT 83
8.3.1 GROWING ADOPTION OF MALE INFERTILITY TREATMENT PROCEDURES TO PROVIDE POTENTIAL GROWTH OPPORTUNITIES 83

9 INFERTILITY TREATMENT MARKET, BY END USER 84
9.1 INTRODUCTION 85
9.2 FERTILITY CENTERS 86
9.2.1 GROWING NUMBER OF INFERTILITY TREATMENT CENTERS WORLDWIDE DRIVING GROWTH OF THIS SEGMENT 86
9.3 HOSPITALS AND SURGICAL CLINICS 87
9.3.1 INITIATIVES UNDERTAKEN BY GOVERNMENTS TO INCREASE THE NUMBER OF HOSPITALS EQUIPPED TO PERFORM INFERTILITY TREATMENT PROCEDURES CONTRIBUTING TO MARKET GROWTH 87
9.4 RESEARCH INSTITUTES 88
9.4.1 GROWING NEED FOR IMPROVING THE CLINICAL EFFICACY OF VARIOUS INFERTILITY TREATMENT OPTIONS DRIVING MARKET GROWTH IN RESEARCH INSTITUTES 88
9.5 CRYOBANKS 89
9.5.1 INCREASING NUMBER OF ART PROCEDURES USING DONOR SPERM AND DONOR EGGS FOR INFERTILITY TREATMENT DRIVING THE DEMAND FOR CRYOBANKS 89
10 INFERTILITY TREATMENT MARKET, BY REGION 91
10.1 INTRODUCTION 92
10.2 NORTH AMERICA 93
10.2.1 US 97
10.2.1.1 US to dominate the infertility treatment market in North America 97
10.2.2 CANADA 99
10.2.2.1 Government initiatives and legislations for same-sex marriages to drive market growth in Canada 99
10.3 EUROPE 101
10.3.1 GERMANY 104
10.3.1.1 Favorable funding scenario for IVF treatments in Germany to drive the growth of the infertility treatment market in the country 104
10.3.2 UK 107
10.3.2.1 Increase in the number of IVF cycles in the UK contributing to market growth 107
10.3.3 FRANCE 109
10.3.3.1 The ART segment dominated the infertility treatment procedures market in France 109
10.3.4 REST OF EUROPE 111
10.4 ASIA PACIFIC 113
10.4.1 JAPAN 115
10.4.1.1 Growing awareness has served to boost the adoption of IVF procedures in Japan 115
10.4.2 CHINA 118
10.4.2.1 Declining newborn population and birth rate in China to drive the demand for infertility treatment procedures in the country 118

10.4.3 INDIA 120
10.4.3.1 Rising fertility medical tourism offering high-growth opportunities for the infertility treatment market in India 120
10.4.4 REST OF ASIA PACIFIC 122
10.5 REST OF THE WORLD 124
10.5.1 LATIN AMERICA 126
10.5.1.1 Latin America to account for the largest share of the Rest of the World infertility treatment market 126
10.5.2 MIDDLE EAST & AFRICA 128
10.5.2.1 Rising incidence of male-factor infertility to drive market growth during the forecast period 128
11 COMPETITIVE LANDSCAPE 131
11.1 OVERVIEW 131
11.2 INFERTILITY TREATMENT: MARKET SHARE ANALYSIS, 2017 131
11.3 COMPETITIVE SCENARIO 132
12 COMPANY PROFILES 135
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 COOK GROUP INCORPORATED 135
12.2 ESCO MICRO PTE. LTD. 137
12.3 GENEA LIMITED 139
12.4 HAMILTON THRONE, LTD. 141
12.5 IHMEDICAL A/S 144
12.6 IRVINE SCIENTIFIC (A MEMBER OF JX HOLDINGS GROUP) 145
12.7 IVFTECH APS 148
12.8 KITAZATO CORPORATION 149
12.9 MEDGYN PRODUCTS, INC. 151
12.10 ROCKET MEDICAL PLC 152
12.11 SOMATEX MEDICAL TECHNOLOGIES GMBH 154
12.12 THE BAKER COMPANY, INC. 155
12.13 THE COOPER COMPANIES, INC. 157
12.14 THERMO FISHER SCIENTIFIC 160
12.15 VITROLIFE AB 163
12.16 ZEISS GROUP 166
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

13 APPENDIX 168
13.1 DISCUSSION GUIDE 168
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 173
13.3 AVAILABLE CUSTOMIZATIONS 175
13.4 RELATED REPORTS 175
13.5 AUTHOR DETAILS 176

...

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 不妊治療の世界市場予測(~2023年)(Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure [ART (IVF, ICSI, Surrogate), Insemination, Laparoscopy, Tubal Ligation], Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Forecasts to 2023)]についてメールでお問い合わせはこちらでお願いします。